Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Lookup NU author(s): Professor Gareth VealORCiD, Dr David JamiesonORCiD, Katja Kuver

Downloads

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).

Publication metadata

Author(s): Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marple M, Veal G, Jamieson D, Küver K, Tirabosco R, Forsyth S, Nash S, Dehbi H, Beare S

Publication type: Article

Publication status: Published

Journal: Lancet Oncology

Year: 2017

Volume: 18

Issue: 10

Pages: 1397-1410

Print publication date: 01/10/2017

Online publication date: 04/09/2017

Acceptance date: 01/08/2017

Date deposited: 07/09/2017

ISSN (print): 1470-2045

ISSN (electronic): 1474-5488

Publisher: Elsevier

URL: https://doi.org/10.1016/S1470-2045(17)30622-8

DOI: 10.1016/S1470-2045(17)30622-8

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
Cancer Research UK (C2921/A11561)
Sarcoma UK (SUK16.2015)

Share